Skip to main content

Aerobic Exercise

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
TrainingN/A1 trial
Active Trials
NCT04758754Recruiting36Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Verona PharmaTraining

Clinical Trials (1)

Total enrollment: 36 patients across 1 trials

Active and Passive Exercise Training in Improving Vascular Function: Local vs Systemic Vascular Effect.

Start: Dec 2023Est. completion: Dec 202436 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 36 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.